MSB 10.4% $1.49 mesoblast limited

Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD, page-80

  1. 17,046 Posts.
    lightbulb Created with Sketch. 2414
    The have financial time pressure to resubmit. As it is they might be cutting it close if there is any further information requested by the FDA.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.